<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:08:51Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/18107" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/18107</identifier><datestamp>2026-10-18T20:56:22Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>The Effect of Resveratrol on Ischemia–Reperfusion Induced Oxidative Rat Ovary Injury: A Biochemical, Histopathological, and Genetic Evaluation</dc:title><dc:creator>SAYAR, ILYAS</dc:creator><dc:creator>Bakan, Nuri</dc:creator><dc:creator>GÜRBÜZEL, MEHMET</dc:creator><dc:creator>Akbaş, Nergis</dc:creator><dc:subject>Tıbbi Araştırmalar Deneysel</dc:subject><dc:subject>Onkoloji</dc:subject><dc:subject>İmmünoloji</dc:subject><dc:subject>Kalp ve Kalp Damar Sistemi</dc:subject><dc:description>Objective: The cellular protective effects of resveratrol and co-enzyme Q10 supplementation have been reported in different models. However, there is insufficient data on the effects of resveratrol supplementation on oxidative DNA damage and co-enzyme Q10 levels in ovarian ischemia–reperfusion injury. The current study aims to investigate how resveratrol supplementation affects oxidative DNA damage, co-enzyme Q10 levels, inflammatory and proinflammatory indicators, and growth factors in ovarian ischemia– reperfusion injury. Methods: Thirty albino Wistar female rats were divided into 5 groups; control, ovarian ischemia–reperfusion, and ischemia–reperfusion + treatment (25, 50, and 100 mg/kg resveratrol). Hematoxylin–eosin stain was used to evaluate histopathological results. The levels of 8-oxo-2ʹ-deoxy guanosine and co-enzyme Q10 were obtained by enzyme-linked immunosorbent assay. Following RNA isolation, the expression of tumor necrosis factor-α , interleukin-1β, transforming growth factor-β3, hepatocyte growth factor, epidermal growth factor, and vascular endothelial growth factor was assessed. Results: Regarding the histopathological evaluation score, 8-oxo -2ʹ-d eoxyg uanos ine levels, and co-enzyme Q10 levels, there was no statistically significant difference between the ischemia–reperfusion group and the groups that received resveratrol treatment. Tumor necrosis factor-α, interleukin-1β, transforming growth factor-β3, hepatocyte growth factor, epidermal growth factor, and vascular endothelial growth factor expression levels were significantly decreased in the resveratrol -treated groups compared to the ischemia–reperfusion group. Conclusion: The results imply that the positive effects of resveratrol on infla mmato ry-pr oinfl ammat ory cytokine expression may be a major contributor to the anti-oxidant, anti-inflammatory, anti-proliferative, anti-carcinogenic, and therapeutic effects of resveratrol documented in the literature.</dc:description><dc:date>2023</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/18107</dc:identifier><dc:identifier>https://doi.org/10.5152/abcr.2023.22046</dc:identifier><dc:identifier>2687-4520</dc:identifier><dc:language>en</dc:language><dc:relation>Archives of Basic and Clinical Research</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/18107</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>